Biocorrx Inc. (OTCMKTS:BICX) Sees Significant Increase in Short Interest

Biocorrx Inc. (OTCMKTS:BICX) was the recipient of a significant increase in short interest during the month of August. As of August 31st, there was short interest totaling 18,093 shares, an increase of ∞ from the August 15th total of 0 shares. Based on an average daily volume of 8,509 shares, the short-interest ratio is presently 2.1 days. Currently, 0.1% of the company’s shares are short sold.

Biocorrx Price Performance

Biocorrx stock opened at $0.25 on Wednesday. The firm has a 50 day simple moving average of $0.26 and a 200-day simple moving average of $0.33. The stock has a market cap of $7.52 million, a price-to-earnings ratio of -2.08 and a beta of 0.19. Biocorrx has a 1-year low of $0.15 and a 1-year high of $1.28.

Biocorrx (OTCMKTS:BICX) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.02. The business had revenue of $0.09 million during the quarter, compared to analysts’ expectations of $0.24 million.

About Biocorrx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.